Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Aleksander Salomon-Perzyński"'
Autor:
Aleksander Salomon-Perzyński, Joanna Barankiewicz, Marcin Machnicki, Irena Misiewicz-Krzemińska, Michał Pawlak, Sylwia Radomska, Agnieszka Krzywdzińska, Aleksandra Bluszcz, Piotr Stawiński, Małgorzata Rydzanicz, Natalia Jakacka, Iwona Solarska, Katarzyna Borg, Zofia Spyra-Górny, Tomasz Szpila, Bartosz Puła, Sebastian Grosicki, Tomasz Stokłosa, Rafał Płoski, Ewa Lech-Marańda, Jana Jakubikova, Krzysztof Jamroziak
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1674 (2022)
Clonal evolution drives treatment failure in multiple myeloma (MM). Here, we used a custom 372-gene panel to track genetic changes occurring during MM progression at different stages of the disease. A tumor-only targeted next-generation DNA sequencin
Externí odkaz:
https://doaj.org/article/157b567d61334d2ca4fc78ec78d72b72
Publikováno v:
Diagnostics, Vol 11, Iss 9, p 1534 (2021)
Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone marrow plasma cells. Malignant transformation of plasma cells depends on the continuity of events resulting in a sequence of well-defined disease stag
Externí odkaz:
https://doaj.org/article/3aff9c3fe5904babaa926e76099ec53c
Publikováno v:
Hematology in Clinical Practice. 14:6-10
Autor:
Joanna Drozd-Sokołowska, Krzysztof Mądry, Joanna Barankiewicz, Katarzyna Kobylińska, Przemysław Biecek, Jagoda Rytel, Ewa Karakulska-Prystupiuk, Kamila Skwierawska, Aleksander Salomon-Perzyński, Tomasz Stokłosa, Grzegorz Władysław Basak
Publikováno v:
Chemotherapy. 68:16-22
Introduction: Venetoclax combined with azacitidine (AZA-VEN) constitutes an option for the treatment of acute myeloid leukemia. There are, however, no data on the COVID-19 incidence and outcome in patients treated with AZA-VEN. Methods: Patients with
Autor:
Aleksander Salomon-Perzyński, Urszula Walczak, Kinga Kos-Zakrzewska, Ewa Lech-Marańda, Bożena Katarzyna Budziszewska
Publikováno v:
Hematology in Clinical Practice. 22:37-40
Autor:
Joanna, Barankiewicz, Aleksander, Salomon-Perzyński, Irena, Misiewicz-Krzemińska, Ewa, Lech-Marańda
Publikováno v:
Cancers. 14(18)
Multiple myeloma (MM) is the second most common hematological malignancy with a recurrent clinical course. The introduction of immunomodulatory drugs (IMiDs) was one of the milestones in MM therapy leading to a significant improvement in patients' pr
Autor:
Andrzej Rydzewski, Agnieszka Końska, Bartosz Pula, Aleksander Salomon-Perzyński, Tomasz Protaziuk, Joanna Sawczuk, Krzysztof Jamroziak
Publikováno v:
Hematologia. 11:50-57
Amyloidoza lancuchow lekkich (amyloidoza AL) to wieloukladowa choroba charakteryzująca sie odkladaniem w roznych narządach zlogow amyloidu powstalego z monoklonalnych lancuchow lekkich immunoglobulin. Podstawą leczenia przyczynowego amyloidozy AL
Autor:
Kari Flicker, Alessandro Gozzetti, Shuhua Yi, Santiago Thibaud, Rebecca Silbermann, Ravi Vij, Iwona Hus, Katarzyna Krzanowska, Julio Davila Valls, Artur Jurczyszyn, Aimee Chappell, Magdalena Olszewska-Szopa, Edvan de Queiroz Crusoe, Aleksander Salomon-Perzyński, Carmen Montes Gaisan, Santosh Kumar Chellapuram, David H. Vesole, Lalit Kumar, Jacek Czepiel, Fang Xu, Joshua Richter, Anna Suska, Mark A. Fiala, Enrique M. Ocio, Jorge J. Castillo, Anna Waszczuk-Gajda
Publikováno v:
Clin Lymphoma Myeloma Leuk . 2022 May;22(5):297-304
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
POEMS syndrome, a rare plasma cell disorder, is challenging both in the diagnostic and therapeutic management. We present real word retrospective analysis of 108 cases analyzing clinical features and therapeutic modes. We compare our results with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e447e366eff5745f637fd8d3edab83c2
https://ruj.uj.edu.pl/xmlui/handle/item/286279
https://ruj.uj.edu.pl/xmlui/handle/item/286279
Autor:
Joanna Barankiewicz, Aleksander Salomon-Perzyński, Irena Misiewicz-Krzemińska, Ewa Lech-Marańda
Publikováno v:
Cancers. 14:4492
Multiple myeloma (MM) is the second most common hematological malignancy with a recurrent clinical course. The introduction of immunomodulatory drugs (IMiDs) was one of the milestones in MM therapy leading to a significant improvement in patients’
Autor:
Irena Misiewicz-Krzemińska, Ewa Lech-Marańda, Aleksander Salomon-Perzyński, Monika Prochorec-Sobieszek, Joanna Barankiewicz, Agata Malenda, Filip Garbicz, Paulina Wieszczy, Anna Szumera-Ciećkiewicz, Przemyslaw Juszczynski
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 2683, p 2683 (2021)
Journal of Clinical Medicine
Volume 10
Issue 12
Journal of Clinical Medicine
Volume 10
Issue 12
Immunomodulatory drugs (IMiDs) are effective in the treatment of multiple myeloma (MM), myelodysplastic syndrome with deletion of chromosome 5q and other haematological malignancies. Recent studies showed that IMiDs bind to cereblon (CRBN), a substra